EUVIMEDEUVIMED entdecken
Crossref

Outcome of rituximab therapy in patients with systemic lupus erythematosus

Hanan Al Rayes, MufaddalAdil Alaithan, Hussein Halabi, MaryamMohammed Shamaa, RawanNaser Alharbi, NuwarIbrahim Aljoma

Annals of Rheumatology and Autoimmunity · 2023

DOI: 10.4103/ara.ara_10_22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Rheumatology and Autoimmunity, 2023. Verfasst von Hanan Al Rayes und 5 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Rayes, H. A., Alaithan, M., Halabi, H., Shamaa, M., Alharbi, R., & Aljoma, N. (2023). Outcome of rituximab therapy in patients with systemic lupus erythematosus. Annals of Rheumatology and Autoimmunity. https://doi.org/10.4103/ara.ara_10_22

Vancouver

Rayes HA, Alaithan M, Halabi H, Shamaa M, Alharbi R, Aljoma N. Outcome of rituximab therapy in patients with systemic lupus erythematosus. Annals of Rheumatology and Autoimmunity. 2023. doi:10.4103/ara.ara_10_22

BibTeX
@article{Rayes2023,
  author = {Rayes, Hanan Al and Alaithan, MufaddalAdil and Halabi, Hussein and Shamaa, MaryamMohammed and Alharbi, RawanNaser and Aljoma, NuwarIbrahim},
  title = {Outcome of rituximab therapy in patients with systemic lupus erythematosus},
  journal = {Annals of Rheumatology and Autoimmunity},
  year = {2023},
  doi = {10.4103/ara.ara_10_22}
}
Kostenlos starten →